Medical Pharmacology: Gastrointestinal Pharmacology Practice Questions
Choose the correct answer for each question.
Duration of suppression of acid secretion following administration of proton pump inhibitors (e.g. omeprazole):
8 hours
12 hours
Up to 1 to 2 days
Greater than four days
Proton pump inhibitors should been administered prior to the first meal of the day since the amount of proton pump ( H+, K+-ATPase) increases following fasting.
True
False
Typical dosing profile/profiles associated with proton pump inhibitors:
Usually a single daily dosing is adequate to ensure effective suppression of acid production.
A second dose, if required, would be administered prior to the evening meal.
Both
Neither
Associated following extended treatment with proton pump inhibitors:
Rebound acid hypersecretion
Acid secretion does not return to pretreatment levels, which may account for long-term protection even in the absence of proton pump drug administration.
Both
Neither
Degradation of proton pump inhibitors following oral administration can occur due to exposure to acid in the gastric lumen. This effect may be limited by use of which one(s) of the following?
Use of enteric-coated pellets in gelatin capsules
Delayed-release oral packets containing drug in suspension.
Both
Neither
This/these proton pump inhibitors can be administered parenterally if the oral route of administration is not an option.
Pantoprazole
Esomeprazole sodium
Both
Neither
Concerning proton pump inhibitor metabolism:
These agents are metabolized by the liver microsomal cytochrome P450 enzyme system.
Asians compared to Caucasians are African-Americans a more likely to exhibit slower proton pump inhibitor metabolism.
Both
Neither
Using once daily dosing of the proton pump inhibitor, this amount of time may be required to achieve 70% inhibition, level noted at equilibrium i.e. the steady-state.
12 hours
24 hours
2-5 days
At least a week
Chronic renal disease including renal failure results in proton pump inhibitor drug accumulation following daily dosing.
True
False
Hepatic disease and possible effect on esomeprazole and lansoprazole clearance.